RxDoctor Payments Data

Ester Salvador, MD

Psychiatry · Bentonville, ARNPI 1225081854

Payments from drug & device makers

$703in general payments, 2019–2025

Across 60 payments — averaging $11.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$233
  • Otsuka America Pharmaceutical, Inc.$112
  • Johnson & Johnson$96
  • Takeda Pharmaceuticals U.S.A., Inc.$80
  • Sunovion Pharmaceuticals Inc.$45
  • Neurocrine Biosciences, Inc.$44
  • plus $93 from 5 others

What the payments were for

  • Food & beverage$703100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$703 in reported general payments places this provider in the 60th percentile of 235 psychiatry providers in Arkansas.

See all psychiatry providers in Arkansas

Medicare billing

Part B allowed, 2024
$5,655
Medicare patients
18
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl12$18,830
Aripiprazole68$1,991
Desvenlafaxine Succinate ErDesvenlafaxine Succinate43$1,118
Hydroxyzine Hcl52$777
Fluoxetine Hcl36$742
Oxcarbazepine21$529
Lamotrigine68$512
Doxazosin Mesylate36$468
Eszopiclone25$444
Gabapentin26$388
Ziprasidone Hcl13$366
Clonazepam37$267
Bupropion XlBupropion Hcl20$267
Alprazolam46$260
Prazosin Hcl21$238

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$233$18,83012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 235 psychiatry providers in Arkansas.

Other psychiatry in Bentonville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →